ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Carbogen expands in Switzerland

by Ann M. Thayer
June 6, 2016 | APPEARED IN VOLUME 94, ISSUE 23

[+]Enlarge
Credit: Carbogen
GEA’s Bubendorf facility, soon to be owned by Carbogen.
Credit: Carbogen
GEA’s Bubendorf facility, soon to be owned by Carbogen.

Drug chemical manufacturer Carbogen Amcis is adding to its operations in Bubendorf, Switzerland. There the company has agreed to acquire a GEA Pharma Systems site close to its current headquarters. The 3,360-m2 multistory building includes lab, small-scale production, storage, and office space. Carbogen intends to convert more of the facility into regulatory compliant operations for highly potent compound development. The company also plans to add manufacturing of antibody-drug conjugates.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment